Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125402092 | 12540209 | 2 | F | 20151224 | 20160713 | 20160708 | 20160726 | EXP | JP-PFIZER INC-2016330888 | PFIZER | 64.00 | YR | F | Y | 54.00000 | KG | 20160726 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125402092 | 12540209 | 1 | PS | ADRIACIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous drip | 360 MG, DAILY | U | 50467 | 360 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
125402092 | 12540209 | 2 | SS | ADRIACIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous drip | 360 MG, DAILY | U | 50467 | 360 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
125402092 | 12540209 | 3 | SS | ADRIACIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous drip | 360 MG, DAILY | U | 50467 | 360 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
125402092 | 12540209 | 4 | SS | ADRIACIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous drip | 360 MG, DAILY | U | 50467 | 360 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
125402092 | 12540209 | 5 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous drip | 220 MG, UNK | U | 22234 | 220 | MG | SOLUTION FOR INJECTION | ||||||
125402092 | 12540209 | 6 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous drip | 220 MG, UNK | U | 22234 | 220 | MG | SOLUTION FOR INJECTION | ||||||
125402092 | 12540209 | 7 | SS | G LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 3.6 MG, 1X/2WEEKS | U | 0 | INJECTION | ||||||||
125402092 | 12540209 | 8 | SS | G LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 3.6 MG, 1X/2WEEKS | U | 0 | INJECTION | ||||||||
125402092 | 12540209 | 9 | SS | G LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 3.6 MG, 1X/2WEEKS | U | 0 | INJECTION | ||||||||
125402092 | 12540209 | 10 | SS | G LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 3.6 MG, 1X/2WEEKS | U | 0 | INJECTION | ||||||||
125402092 | 12540209 | 11 | SS | G LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 3.6 MG, 1X/2WEEKS | U | 0 | INJECTION | ||||||||
125402092 | 12540209 | 12 | SS | G LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 3.6 MG, 1X/2WEEKS | U | 0 | INJECTION | ||||||||
125402092 | 12540209 | 13 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 3600 MG, DAILY | U | 0 | 3600 | MG | INJECTION | ||||||
125402092 | 12540209 | 14 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 3600 MG, DAILY | U | 0 | 3600 | MG | INJECTION | ||||||
125402092 | 12540209 | 15 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 3600 MG, DAILY | U | 0 | 3600 | MG | INJECTION | ||||||
125402092 | 12540209 | 16 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 3600 MG, DAILY | U | 0 | 3600 | MG | INJECTION | ||||||
125402092 | 12540209 | 17 | C | GRANISETRON | GRANISETRON | 1 | Intravenous drip | 3MG, 1X/2WEEKS | 0 | INJECTION | |||||||||
125402092 | 12540209 | 18 | C | DECADRON | DEXAMETHASONE | 1 | Intravenous drip | 6.5999999MG, 1X/2WEEKS | 13.1999998 | MG | 0 | ||||||||
125402092 | 12540209 | 19 | C | DECADRON | DEXAMETHASONE | 1 | Intravenous drip | 1.65 MG, 2X/DAY | 13.1999998 | MG | 0 | 1.65 | MG | BID | |||||
125402092 | 12540209 | 20 | C | ISOTONIC SODIUM CHLORIDE SOLUTION | SODIUM CHLORIDE | 1 | Intravenous drip | 50ML, 1X/2WEEKS | 0 | INJECTION | |||||||||
125402092 | 12540209 | 21 | C | SEISHOKU | SODIUM CHLORIDE | 1 | Intravenous drip | 10ML, 1X/2WEEKS | 0 | INJECTION | |||||||||
125402092 | 12540209 | 22 | C | SEISHOKU | SODIUM CHLORIDE | 1 | Intravenous drip | 250ML, 1X/2WEEKS | 0 | INJECTION | |||||||||
125402092 | 12540209 | 23 | C | SEISHOKU | SODIUM CHLORIDE | 1 | Intravenous drip | 100ML, 1X/2WEEKS | 0 | INJECTION | |||||||||
125402092 | 12540209 | 24 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, 2X/DAY | 24 | MG | 0 | 4 | MG | TABLET | BID | ||||
125402092 | 12540209 | 25 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, 2X/DAY | 24 | MG | 0 | 4 | MG | TABLET | BID | ||||
125402092 | 12540209 | 26 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, 2X/DAY | 24 | MG | 0 | 4 | MG | TABLET | BID | ||||
125402092 | 12540209 | 27 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, 2X/DAY | 24 | MG | 0 | 4 | MG | TABLET | BID | ||||
125402092 | 12540209 | 28 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, 2X/DAY | 24 | MG | 0 | 4 | MG | TABLET | BID | ||||
125402092 | 12540209 | 29 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, 2X/DAY | 24 | MG | 0 | 4 | MG | TABLET | BID | ||||
125402092 | 12540209 | 30 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 5 MG, 3X/DAY | 50 | MG | 0 | 5 | MG | TABLET | TID | ||||
125402092 | 12540209 | 31 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 5 MG, 3X/DAY | 50 | MG | 0 | 5 | MG | TABLET | TID | ||||
125402092 | 12540209 | 32 | C | EMEND | APREPITANT | 1 | Oral | 80 MG, DAILY | 0 | 80 | MG | CAPSULE | |||||||
125402092 | 12540209 | 33 | C | EMEND | APREPITANT | 1 | Oral | 80 MG, DAILY | 0 | 80 | MG | CAPSULE | |||||||
125402092 | 12540209 | 34 | C | EMEND | APREPITANT | 1 | Oral | 80 MG, DAILY | 0 | 80 | MG | CAPSULE | |||||||
125402092 | 12540209 | 35 | C | EMEND | APREPITANT | 1 | Oral | 80 MG, DAILY | 0 | 80 | MG | CAPSULE | |||||||
125402092 | 12540209 | 36 | C | Alosen | 2 | Oral | 5 MG, DAILY | 0 | 5 | MG | GRANULES | ||||||||
125402092 | 12540209 | 37 | C | Alosen | 2 | Oral | 5 MG, DAILY | 0 | 5 | MG | GRANULES | ||||||||
125402092 | 12540209 | 38 | C | Alosen | 2 | Oral | 5 MG, DAILY | 0 | 5 | MG | GRANULES | ||||||||
125402092 | 12540209 | 39 | C | CIPROXAN | CIPROFLOXACIN | 1 | Oral | 200 MG, 3X/DAY | 1.8 | G | 0 | 200 | MG | TABLET | TID | ||||
125402092 | 12540209 | 40 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | Rectal | 50MG, 6X/DAY | 0 | SUPPOSITORY | |||||||||
125402092 | 12540209 | 41 | C | CARDENALIN | DOXAZOSIN MESYLATE | 1 | Oral | 2 MG, DAILY | 0 | 2 | MG | ORODISPERSIBLE TABLET | |||||||
125402092 | 12540209 | 42 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 2.5 MG, DAILY | 0 | 2.5 | MG | TABLET | |||||||
125402092 | 12540209 | 43 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 2.5 MG, DAILY | 0 | 2.5 | MG | TABLET | |||||||
125402092 | 12540209 | 44 | C | NIFEDIPINE CR | NIFEDIPINE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | |||||||
125402092 | 12540209 | 45 | C | LOXOPROFEN SODIUM HYDRATE | LOXOPROFEN SODIUM DIHYDRATE | 1 | Oral | 60 MG, DAILY | 0 | 60 | MG | TABLET | |||||||
125402092 | 12540209 | 46 | C | LOXOPROFEN SODIUM HYDRATE | LOXOPROFEN SODIUM DIHYDRATE | 1 | Oral | 60 MG, DAILY | 0 | 60 | MG | TABLET | |||||||
125402092 | 12540209 | 47 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
125402092 | 12540209 | 48 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
125402092 | 12540209 | 49 | C | HIRUDOID | GLYCOSAMINOGLYCANS | 1 | Topical | 50G, FREQUENCY UNKNOWN | 0 | OINTMENT | |||||||||
125402092 | 12540209 | 50 | C | HIRUDOID | GLYCOSAMINOGLYCANS | 1 | Topical | 50G, FREQUENCY UNKNOWN | 0 | OINTMENT | |||||||||
125402092 | 12540209 | 51 | C | MYSER | DIFLUPREDNATE | 1 | Topical | 10G, FREQUENCY UNKNOWN | 0 | OINTMENT |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125402092 | 12540209 | 1 | Breast cancer |
125402092 | 12540209 | 7 | Colony stimulating factor prophylaxis |
125402092 | 12540209 | 13 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125402092 | 12540209 | OT |
125402092 | 12540209 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125402092 | 12540209 | Cerebral infarction | |
125402092 | 12540209 | Inappropriate schedule of drug administration | |
125402092 | 12540209 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125402092 | 12540209 | 1 | 20151221 | 20151221 | 0 | |
125402092 | 12540209 | 2 | 20160104 | 20160104 | 0 | |
125402092 | 12540209 | 3 | 20160118 | 20160118 | 0 | |
125402092 | 12540209 | 4 | 20160201 | 20160201 | 0 | |
125402092 | 12540209 | 5 | 20160215 | 0 | ||
125402092 | 12540209 | 6 | 20160229 | 20160229 | 0 | |
125402092 | 12540209 | 7 | 20151222 | 20151222 | 0 | |
125402092 | 12540209 | 8 | 20160105 | 20160105 | 0 | |
125402092 | 12540209 | 9 | 20160119 | 20160119 | 0 | |
125402092 | 12540209 | 10 | 20160202 | 20160202 | 0 | |
125402092 | 12540209 | 11 | 20160216 | 20160216 | 0 | |
125402092 | 12540209 | 12 | 20160301 | 20160301 | 0 | |
125402092 | 12540209 | 13 | 20151221 | 20151221 | 0 | |
125402092 | 12540209 | 14 | 20160104 | 20160104 | 0 | |
125402092 | 12540209 | 15 | 20160118 | 20160118 | 0 | |
125402092 | 12540209 | 16 | 20160201 | 20160201 | 0 | |
125402092 | 12540209 | 17 | 20151221 | 20160201 | 0 | |
125402092 | 12540209 | 18 | 20151221 | 20160229 | 0 | |
125402092 | 12540209 | 19 | 20151221 | 20160201 | 0 | |
125402092 | 12540209 | 20 | 20151221 | 20160201 | 0 | |
125402092 | 12540209 | 21 | 20151221 | 20160201 | 0 | |
125402092 | 12540209 | 22 | 20151221 | 20160229 | 0 | |
125402092 | 12540209 | 23 | 20160215 | 20160229 | 0 | |
125402092 | 12540209 | 24 | 20151221 | 20151223 | 0 | |
125402092 | 12540209 | 25 | 20160104 | 20160106 | 0 | |
125402092 | 12540209 | 26 | 20160201 | 20160203 | 0 | |
125402092 | 12540209 | 27 | 20160215 | 20160217 | 0 | |
125402092 | 12540209 | 28 | 20160229 | 20160302 | 0 | |
125402092 | 12540209 | 29 | 20160118 | 20160120 | 0 | |
125402092 | 12540209 | 30 | 20151221 | 20151225 | 0 | |
125402092 | 12540209 | 31 | 20160104 | 20160108 | 0 | |
125402092 | 12540209 | 32 | 20151221 | 20151222 | 0 | |
125402092 | 12540209 | 33 | 20160104 | 20160105 | 0 | |
125402092 | 12540209 | 34 | 20160118 | 20160119 | 0 | |
125402092 | 12540209 | 35 | 20160201 | 20160202 | 0 | |
125402092 | 12540209 | 36 | 20151221 | 20151227 | 0 | |
125402092 | 12540209 | 37 | 20160104 | 20160110 | 0 | |
125402092 | 12540209 | 38 | 20160118 | 20160124 | 0 | |
125402092 | 12540209 | 39 | 20151221 | 20151223 | 0 | |
125402092 | 12540209 | 40 | 20151221 | 20151221 | 0 | |
125402092 | 12540209 | 41 | 20151222 | 20160111 | 0 | |
125402092 | 12540209 | 42 | 20151222 | 20160111 | 0 | |
125402092 | 12540209 | 43 | 20160126 | 20160305 | 0 | |
125402092 | 12540209 | 44 | 20160126 | 20160305 | 0 | |
125402092 | 12540209 | 45 | 20160215 | 20160224 | 0 | |
125402092 | 12540209 | 46 | 20160229 | 20160305 | 0 | |
125402092 | 12540209 | 47 | 20160215 | 20160224 | 0 | |
125402092 | 12540209 | 48 | 20160229 | 20160305 | 0 | |
125402092 | 12540209 | 49 | 20160215 | 20160215 | 0 | |
125402092 | 12540209 | 50 | 20160229 | 20160229 | 0 | |
125402092 | 12540209 | 51 | 20160229 | 20160229 | 0 |